S-nitrosylation: spectrum and specificity

Douglas T. Hess(Howard Hughes Medical Institute), Jonathan S. Stamler(Discovery Institute), Akio Matsumoto(Kirin (Japan)), Raphael Nudelman(Teva Pharmaceuticals (Israel))
Nature Cell Biology
February 1, 2001
10.1038/35055152
Cited by 243

Related Papers

OxyR
|Cell|2002|474
Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
|Nature Clinical Practice Rheumatology|2008|197
Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein
|Antiviral Research|2008|144
An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT<sub>1A</sub> Agonist (PRX-00023) for the Treatment of Anxiety and Depression
|Journal of Medicinal Chemistry|2006|141
Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65
|Science Signaling|2014|139